Tel Aviv Sourasky Medical Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Tel Aviv Sourasky Medical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9317
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tel Aviv Sourasky Medical Center (Sourasky Medical) is an academic medical center that provides patient-centered care, research and education services. The center offers services in the areas of cardiology, dermatology, gastroenterology, general surgery, genetics, emergency medicine, rheumatology, neurology, oncology, and others. It provides services such as ophthalmology, endocrinology, infectious diseases, hematology, and others. Sourasky Medical also provides language translation; admission room, inpatient units, and maternity care, death and burial services, accessibility for people with disabilities, and others. The center offers service such as food and beverage, bewell program, medical records, private nursing and ambulance service, religious services, equipment rental and other support services. Sourasky Medical is headquartered in Tel Aviv, Israel.

Tel Aviv Sourasky Medical Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tel Aviv Sourasky Medical Center, Medical Devices Deals, 2012 to YTD 2018 9
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Pluristem Enters into Agreement with Tel Aviv Sourasky 11
Therapix Biosciences Enters into Agreement with Weizmann Institute and Tel Aviv Sourasky 12
Kite Pharma Extends Research Agreement with Tel Aviv Medical Center to Develop Novel Chimeric Antigen Receptor (CAR) 13
Kite Pharma Enters into Research Agreement with Tel Aviv Medical Center 14
Tel Aviv Sourasky Medical Center – Key Competitors 15
Tel Aviv Sourasky Medical Center – Key Employees 16
Tel Aviv Sourasky Medical Center – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Key Facts 2
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tel Aviv Sourasky Medical Center, Deals By Therapy Area, 2012 to YTD 2018 8
Tel Aviv Sourasky Medical Center, Medical Devices Deals, 2012 to YTD 2018 9
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Pluristem Enters into Agreement with Tel Aviv Sourasky 11
Therapix Biosciences Enters into Agreement with Weizmann Institute and Tel Aviv Sourasky 12
Kite Pharma Extends Research Agreement with Tel Aviv Medical Center to Develop Novel Chimeric Antigen Receptor (CAR) 13
Kite Pharma Enters into Research Agreement with Tel Aviv Medical Center 14
Tel Aviv Sourasky Medical Center, Key Competitors 15
Tel Aviv Sourasky Medical Center, Key Employees 16
Tel Aviv Sourasky Medical Center, Subsidiaries 17

List of Figures
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Tel Aviv Sourasky Medical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Tel Aviv Sourasky Medical Center, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Tel Aviv Sourasky Medical Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shanghai Electric Group Co Ltd:企業の戦略・SWOT・財務情報
    Shanghai Electric Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Shanghai Electric Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • SuperSonic Imagine SA (SSI):医療機器:M&Aディール及び事業提携情報
    Summary SuperSonic Imagine SA (SuperSonic) is a medical device company that develops and supplies ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company offers ultrasound system, aixplorer that finds clinical applications in breast, abdomen, liver, vascular, …
  • Lansen Pharmaceutical Holdings Ltd (503):企業の財務・戦略的SWOT分析
    Summary Lansen Pharmaceutical Holdings Ltd (Lansen), a subsidiary of Cathay International Holdings Ltd is a pharmaceutical that develops, produces and sales specialty prescription western pharmaceuticals for the treatment of rheumatic diseases. The company’s products comprise specialist medicine, Ch …
  • Xylem Inc (XYL):石油・ガス:M&Aディール及び事業提携情報
    Summary Xylem Inc (Xylem) is a water technology company. It designs, manufactures, and services engineered solutions ranging across a wide variety of applications. The company’s offerings address customer needs across the water cycle, from the delivery, measurement and use of drinking water to the c …
  • Exelon Corporation:企業のM&A・事業提携・投資動向
    Exelon Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Exelon Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Estel Technologies Pvt. Ltd:企業の戦略的SWOT分析
    Estel Technologies Pvt. Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Recipharm AB (RECI B):製薬・医療:M&Aディール及び事業提携情報
    Summary Recipharm AB (Recipharm) is a contract development and manufacturing organization (CDMO) that offers manufacturing, and development and technology services. The organization's manufacturing segment provides contract manufacturing of pharmaceuticals such as semi-solids, and oral liquids, soli …
  • Mereo Biopharma Group Plc (MPH):企業の財務・戦略的SWOT分析
    Summary Mereo Biopharma Group Plc (Mereo), formerly Mereo Biopharma Group Ltd is a specialty bio-pharmaceutical company which develops novel medicines for the treatment of rare and specialty diseases. The company’s pipeline products include BPS-804, which is used for the treatment of brittle bone sy …
  • Alon USA Energy Inc (ALJ)-石油・ガス分野:企業M&A・提携分析
    Summary Alon USA Energy Inc (Alon USA), a subsdiary of Delek US Holdings, Inc., is a refiner and marketer of petroleum products. The products offered by the company include various grades of gasoline, diesel fuel, jet fuel, petrochemicals, petrochemical feedstocks, asphalt, and other petroleum-based …
  • Lipocine Inc (LPCN):企業の財務・戦略的SWOT分析
    Summary Lipocine Inc (Lipocine) is a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testosterone produ …
  • GNI Group Ltd (2160):企業の財務・戦略的SWOT分析
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery and …
  • Heidelberg Pharma AG (HPHA):企業の財務・戦略的SWOT分析
    Heidelberg Pharma AG (HPHA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Securitas AB:企業の戦略・SWOT・財務情報
    Securitas AB - Strategy, SWOT and Corporate Finance Report Summary Securitas AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • McKesson Corporation:企業の戦略・SWOT・財務情報
    McKesson Corporation - Strategy, SWOT and Corporate Finance Report Summary McKesson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Reliance Capital Ltd:企業のM&A・事業提携・投資動向
    Reliance Capital Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Reliance Capital Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Laboratory Corp of America Holdings (LH)-製薬・医療分野:企業M&A・提携分析
    Summary Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics la …
  • Tohoku Electric Power Co Inc:発電所・企業SWOT分析
    Tohoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Maxion Wheels Inc:企業の戦略的SWOT分析
    Maxion Wheels Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Pearl Global Industries Limited
    Pearl Global Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Pearl Global Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆